AzTrials
AzTrials

StrabismusNCT03507712

Symmetrical Versus Asymmetrical Surgery for Asymmetrical Inferior Oblique Overaction

A study testing Symmetrical IO weakening and Asymmetrical IO weakening in people with Strabismus, run by Sultan Qaboos University at 1 site in Oman.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Overaction of the inferior oblique (IO) muscle is a commonly observed component of childhood strabismus, and is often seen combined with other ocular deviations. It manifests with excessive elevation of the affected eye in adduction, and may cause a pattern strabismus and vertical deviation of the affected eye. Read more about this study

Who is it for?
Any age
Conditions the study is for
Strabismus
What is being tested?
Symmetrical IO weakening and Asymmetrical IO weakening
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28 participants
Where
1 siteOman
Study dates
1 Jul 2017to 1 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Comitant esotropia or exotropia with bilateral, asymmetrical IOOA
  • Vertical deviation in primary position < 15 PD
  • Minimum of 3 months follow up

Who cannot join

  • Paralytic or Restrictive Strabismus
  • Dissociated vertical deviation
  • History of previous IO surgery

Trial locations and contacts

1 site in 1 country.

Anuradha Ganesh, MD contact

24144547

gananu@gmail.com

Oman1 site, 1 recruiting
  • Sultan Qaboos University

    Muscat

    Anuradha Ganesh, MD, 24144547, gananu@gmail.com

    Sana Al Zuhaibi, MD

    Recruiting

Other trials in Oman

About this study

Official title: Symmetrical Versus Asymmetrical Inferior Oblique Muscle Weakening Surgery for Asymmetrical Inferior Oblique Overaction

Overaction of the inferior oblique (IO) muscle is a commonly observed component of childhood strabismus, and is often seen combined with other ocular deviations. It manifests with excessive elevation of the affected eye in adduction, and may cause a pattern strabismus and vertical deviation of the affected eye. IO overaction (IOOA) may be primary or secondary to superior oblique underaction, is often bilateral, and may be symmetrical or asymmetrical.

Surgical management of the overacting IO muscle is often required to achieve ocular alignment. The most commonly performed IO muscle weakening procedures are IO myectomy and graded IO recession. The surgical decision is primarily based on degree of overaction of the IO muscle. Various studies have compared the two IO weakening procedures and have reported a similar success rate for both procedures.

The aim of this study is to compare the effect of two IO weakening procedures (symmetrical vs asymmetrical myectomy or graded recession) in normalizing the IOOA, obtaining vertical alignment and collapse of pattern, when employed in the treatment of asymmetrical IOOA.

Read the detailed description
  1. Background (Introduction): An excessive elevation of the eyeball on adduction, both on horizontal movement and in upgaze, is often due to inferior oblique over action (IOOA). It is a common disorder of ocular motility, and is usually bilateral and asymmetrical. The asymmetry may be due to difference in time of onset or difference in degree of severity of the IO overaction in the two eyes. IOOA may be primary and of unknown etiology, or secondary to a congenital superior oblique palsy. Primary IOOA is commonly associated with congenital esotropia, with the oblique overaction usually presenting after one year of age. In addition to congenital esotropia, primary IO overaction may be associated with exotropia or may occur as an isolated IO overaction without other strabismus. IOOA can be isolated or combined with other types of deviations. Primary IOOA has been reported to develop between one to six years of age in up to two-thirds of patients with infantile esotropia, and is usually bilateral. The cause is unknown. IOOA may be seen in 70% of patients with esotropia and in 30% of patients with exotropia. Secondary IOOA is often unilateral and is caused by paresis or paralysis of the superior oblique muscle. Depending on severity, IOOA is graded as: (+1) to (+4) overaction. A (+1) overaction indicates slight over elevation in adduction, and (+4) overaction indicates severe over elevation in adduction. It has been suggested that (+1), (+2), (+3) and (+4) overactions roughly translate to 5, 10, 15 and 20 prism diopter (PD) of hypertropia on side gaze. Clinically, in addition to the excessive elevation of the eye ball on adduction, IOOA may be associated with "V" pattern of strabismus and vertical deviation in primary position. A "V" pattern is relative divergence on the up gaze and convergence on down gaze. When the eyes converge more than 15 PD from upgaze to downgaze, the "V" pattern is said to be significant. With the eyes in the lateral gaze to the opposite side, alternate cover testing shows that the higher eye refixates with a downward movement and that the lower eye does so with an upward movement. Although patients with IOOA present with an excessively elevated eye in adduction, there is little vertical deviation in the primary position, when the condition is bilateral and symmetrical. In contrast, unilateral IOOA or bilateral and asymmetrical IOOA is associated with a significant vertical deviation in the primary position. All patients with strabismus undergo full ocular and orthoptic examinations. The angle of strabismus is measured by prisms and alternate cover test for distant and near in primary position of gaze. In distance fixation, the strabismus angle is also measured in secondary positions of gaze to detect presence of pattern deviation or incomitance. Surgery to weaken the IO muscle is indicated when the muscle is overacting and is associated with a significant "V" pattern or vertical deviation. There are various surgical techniques for weakening an overacting IO muscle. Most commonly used techniques these days are IO myectomy, graded recession and anteriorization. Normalization of the IOOA, vertical ocular alignment within + 5 PD of orthotropia and collapse of pattern are considered ideal outcomes for the surgery. There are many studies comparing IO myectomy and IO recession and all have concluded that they have a similar success rate. However, no study has been conducted to evaluate the effectivity of symmetrical weakening procedures (bilateral myectomy or bilateral equal graded recession) vs asymmetrical procedures (myectomy - recession / bilateral recession of different amounts) in achieving ocular alignment in patients with asymmetrical IOOA. The effect of presence of superior oblique underaction preoperative vertical deviation on the outcome of the surgery has also not been studied to date.
  2. Aim of the study : To compare the effect of symmetrical vs asymmetrical Inferior oblique (IO) weakening procedures when employed in the treatment of asymmetrical Inferior oblique over action (IOOA) in : Primary objective: Normalizing IO action Secondary objectives: Correcting vertical deviation and "V" pattern
  3. Material and Methods: A randomized, interventional clinical trial. All Patients with asymmetrical IOOA, requiring surgical correction (IO weakening procedure) from July 2017 to June 2020 will be prospectively recruited. Prior to surgery all patients will undergo full comprehensive ocular examination, standard orthoptic evaluation and cycloplegic refraction. Minimum of two investigators will assess the preoperative angles of strabismus in a standard manner for each patient. Standard 9-gaze photos will be taken for each patient. Standardized surgical procedure will be followed in all patients according to the grade of IOOA, extent of the "V" pattern and the degree of vertical deviation in primary position. Only patients with a minimal period of 3 months of follow up will be selected for analysis.
  4. Randomization: Patients will be randomly allocated to symmetrical or asymmetrical surgery using permuted block randomization of sizes 2, 4 or 6 (SAS 9.1.3). If symmetrical surgery is planned, then surgical plan for more severe IOOA will be considered for both eyes.
  5. Sample size: The study is designed to show that symmetrical surgery is non inferior to asymmetrical surgery. Sample size was estimated considering a study power of 0.8 with an alpha error of 0.05, aiming to detect a difference of 5 PD in the angle of strabismus between the two groups and a postoperative standard deviation (SD) of 5.3. Based on this estimation, a total of 14 patients was found to be adequate in each group.
  6. Statistical analysis:

The baseline quantitative variables will be expressed using mean with SD across the two groups if the distribution of the variables are symmetric. If not, then median with interquartile range will be presented across the groups. The baseline categorical variables will be presented using frequencies and percentages across the groups.

Primary outcomes: The difference in pre- and post-operative measurements (mean and SD) will be calculated for both the groups. The 95% confidence interval (CI) for the difference in change will then be calculated. If there are any clinical differences in the baseline parameters, then analysis of co-variance will be used to compare the change across the groups adjusted for the baseline values. If the lower limit of the CI is within 5 units, then symmetrical surgery will be concluded non-inferior to asymmetrical surgery. Intention to Treat and per-protocol analysis will be done for the primary outcome.

Secondary outcomes: The secondary outcomes will be compared across the groups using independent t-test or Wilcoxon rank sum test depending on the distribution of the continuous variables. Fisher's exact test will be used to compare categorical variables across the groups.

Conditions
Strabismus
Being tested
Symmetrical IO weakening, Asymmetrical IO weakening
Keywords
Asymmetric, Inferior Oblique, Overaction, Surgery, Symmetric
Medical subject headings
Strabismus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Symmetrical IO weakeningProcedure or surgery

    Bilateral IO Myectomy / Bilateral equal graded IO Recession

  • Asymmetrical IO weakeningProcedure or surgery

    IO Myectomy in one eye - IO Recession in the fellow eye / Bilateral IO Recession (different amounts) in each eye

Study groups in NCT03507712
Study groupRoleWhat they receive
Symmetrical IO weakening.Active comparatorSame surgery in both eyes
Receives: Procedure: Symmetrical IO weakening
Asymmetrical IO weakening.Active comparatorDifferent amounts or different surgery in each eye
Receives: Procedure: Asymmetrical IO weakening

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Normalization of IO action

    To compare effect of symmetrical vs asymmetrical IO weakening in reducing IOOA (scale of +1 to +4)

    Measured: 3 months

Secondary outcomes (2)
  1. Vertical ocular alignment

    To compare the effect of symmetrical vs asymmetrical IO weakening in producing vertical alignment (within 3 PD of orthotropia)

    Measured: 3 months

  2. Collapse of "V" pattern

    To compare the effect of symmetrical vs asymmetrical IO weakening in collapsing the "V" pattern (difference in deviation in upgaze and downgaze within 5 PD)

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2018
  2. Study start1 Jul 2017
  3. Primary completion1 Dec 2020 (estimated)
  4. Study completion1 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group I: Symmetrical IO weakening surgery - Bilateral IO Myectomy / Bilateral equal graded IO Recession (Same surgery in both eyes). Group II: Asymmetrical IO weakening surgery - IO Myectomy in one eye - IO Recession in the fellow eye / Bilateral IO Recession (different amounts) in each eye.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
28 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03507712
Sponsor's protocol ID
MREC 1474
Status last verified
Aug 2020
First submitted
15 Apr 2018
Last updated
6 Aug 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Symmetrical IO weakening and Asymmetrical IO weakening in people with Strabismus, run by Sultan Qaboos University at 1 site in Oman.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Oman. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Anuradha Ganesh, MD (24144547, gananu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Normalization of IO action (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in